Thrombin-responsive reticular polymer and application thereof
A technology of thrombin and polymer, which is applied in the field of thrombin-responsive network polymer and its application in the delivery of closed-loop thrombin inhibitors, can solve the problems of adverse reactions and low bioavailability, and achieve the goal of improving thrombus target effect on efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0053] Preparation and evaluation of "closed-loop regulation" single-molecule protein nanocapsules
[0054] 1. Preparation of single-molecule protein nanocapsules loaded with peptide or protein-like thrombin inhibitors
[0055] 1. Preparation of single-molecule protein nanocapsules (ctNCs) with thrombus targeting and thrombin responsiveness
[0056] Using solid-phase synthesis (Merrifield, R.B., Solid phase synthesis. Science 1986, 232, 341-348), synthesize thrombin-degradable peptide G(allyl) with N-terminal and C-terminal modification of allylglycine (G(allyl)) -PPRSFL-G(allyl) and the thrombus targeting peptide G(allyl)-CREKA with G(allyl) modified at the N-terminus.
[0057] Dissolve 1 mg of peptide or protein thrombin inhibitors hirudin (HV), lepirudin (Lep), desirudin (Des) and bivalirudin (Biv) in 1 mL of carbonate buffer (5 mM , pH 9.0), N-isopropylacrylamide (40mg), G(allyl)-PPRSFL-G(allyl) (10mg) and G(allyl)-CREKA (5mg) were added sequentially under stirring in an...
Embodiment 2
[0097] Preparation and evaluation of "closed-loop regulation" nanogel
[0098] 1. Preparation of nanogels loaded with thrombin inhibitors
[0099] 1. Preparation of nanogels (ctNGs) with thrombus targeting and thrombin responsiveness
[0100] The thrombus-targeting peptide G(allyl)-GCR(NMe)EKA modified with G(allyl) at the N-terminal and the thrombin-degradable peptide G(allyl)-GGLVPRGSGG modified with G(allyl) at both ends were synthesized by solid-phase synthesis -G (allyl).
[0101] The thrombin inhibitors hirudin (HV), lepirudin (Lep), desirudin (Des), bivalirudin (Biv), dabigatran etexilate (Dab), argatroban ( Arg), d-phenylalanyl-1-prolyl arginine-chloromethyl ketone (PPACK), enoxagatran (Ino), melagatran (Mel), ximelagatran (Xim), or RWJ-671818(RWJ) and acrylamide (AAm), G(allyl)-GCR(NMe)EKA, G(allyl)-GGLVPRGSGG-G(allyl)(60:2:1,mol:mol:mol) and dissolved In 0.5 mL of water, the aqueous phase was obtained. Docusate sodium (356 mg) and laureth (688 mg) were dissolved...
Embodiment 3
[0150] Preparation and evaluation of "closed-loop regulation" hydrogel
[0151] 1. Construction of "closed-loop regulation" hydrogel loaded with thrombin inhibitors
[0152] 1. Preparation of thrombus-targeting and thrombin-responsive hydrogel (ctHG)
[0153] 1 mg thrombin inhibitors hirudin (HV), lepirudin (Lep), desirudin (Des), bivalirudin (Biv), dabigatran etexilate (Dab), argatroban (Arg), d-phenylalanyl-1-prolyl arginine-chloromethyl ketone (PPACK), enoxagatran (Ino), melagatran (Mel), simelagatran (Xim) , RWJ-671818(RWJ) and methacrylamide, thrombin response peptide G(allyl)-TPRSFL-G(allyl), glycoprotein receptor antagonist G(allyl)RGD(60:2:1,mol:mol :mol) were mixed and dissolved in 2 mL of normal saline, then APS (5 mg) and TEMED (10 μL) were added, and left to stand for 5 min to form a hydrogel (ctHG).
[0154] The results show that the hydrogel can carry various thrombin inhibitors, and HV / ctHG, Lep / ctHG, Des / ctHG, Biv / ctHG, Dab / ctHG, Arg / ctHG, PPACK / ctHG, Ino / ct...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com